XML 35 R20.htm IDEA: XBRL DOCUMENT v3.3.1.900
Other Income
 12 Months Ended
Dec. 31, 2015
Other Income and Expenses [Abstract]  
Other Income
OTHER INCOME
Other income for the years ended December 31 consists of the following ($ in millions):
 
2015
 
2014
 
2013
Gain on sale of marketable equity securities
$
12.4

 
$
122.6

 
$
201.5

Gain on sale of unconsolidated joint venture
—

 
—

 
229.8

Gain on sale of a product line
—

 
33.9

 
—

Total
$
12.4

 
$
156.5

 
$
431.3


During 2015, the Company received cash proceeds of $43 million from the sale of certain marketable equity securities and recorded a pretax gain related to these sales of $12 million ($8 million after-tax or $0.01 per diluted share). During 2014, the Company received cash proceeds of $167 million from the sale of certain marketable equity securities and recorded a pretax gain related to these sales of $123 million ($77 million after-tax or $0.11 per diluted share). During the fourth quarter of 2013, the Company sold 5 million of the 8 million shares of Align Technology, Inc. (“Align”) common stock that the Company received in 2009 as a result of a settlement between Align and Ormco Corporation, a wholly-owned subsidiary of the Company. The Company received cash proceeds of $251 million from the sale of these marketable equity securities and recorded a pretax gain of $202 million ($125 million after-tax or $0.18 per diluted share).
Refer to Note 3 for information related to the $34 million gain on the Company’s divestiture of its EVS/hybrid product line in 2014 and the $230 million gain on the sale of the Company’s equity interest in Apex in 2013.